Loading provider…
Loading provider…
Nephrology Physician in Birmingham, AL
NPI: 1073533824Primary Employer
University of Alabama Health Services Foundation, PC.
uabmedicine.org
HQ Phone
Get Ashita's Phone Numberphone_androidMobile
Get Ashita's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardAL State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 77 | 101 |
| 2 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 57 | 101 |
| 3 | 90935Hemodialysis procedure with one physician evaluation | 46 | 70 |
| 4 | 90945Dialysis procedure including one evaluation | 46 | 182 |
| 5 | 99223Initial hospital inpatient care, typically 70 minutes per day | 42 | 42 |
Pharmacokinetics and Pharmacodynamics of Extended Infusion Versus Short Infusion Piperacillin-Tazobactam in Critically Ill Patients Undergoing CRRT.
Authors: Phillip Madonia, Charbel Salem, Milen Amde, Edward Gould, Peilin Wei
Publication Date: 2015-09-25
Quality Improvement Goals for Acute Kidney Injury.
Authors: Ravindra Mehta, Michael Heung, Paul Palevsky, Francis Wilson, Edward Siew, Mitchell Rosner, Azra Bihorac, Luis Juncos
Publication Date: 2019-05
Lead Sponsor: Unity Health Toronto
Collaborators: Canadian Institutes of Health Research (CIHR), Baxter Healthcare Corporation, National Health and Medical Research Council, Australia, The George Institute, National Institute for Health Research, United Kingdom, Medical Research Institute of New Zealand, Health Research Council, New Zealand
Intervention / Treatment: OTHER: Standard RRT initiation, OTHER: Accelerated RRT initiation
Lead Sponsor: AM-Pharma
Collaborators: PPD Development, LP
Intervention / Treatment: OTHER: Placebo, BIOLOGICAL: recAP
Lead Sponsor: Vantive Health LLC
Collaborators: Baxter Healthcare Corporation
Intervention / Treatment: DRUG: Prismocitrate 18, OTHER: No Anticoagulation